King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Eyad Almidani, MD, MBA
Dr. Eyad Almidani, MD, MBA, is a senior Consultant Neonatologist, Associate Professor of Pediatrics, and Deputy Chief Quality Officer in Riyadh, Saudi Arabia, with international training and a research record across neonatal critical care. A leading neonatologist in Riyadh, Saudi Arabia, he is University of Toronto fellowship-trained and an active clinical researcher on Rh alloimmunization, NEC, and neonatal vitamin D outcomes.Senior Consultant Neonatologist with 20+ years of clinical experienceUniversity of Toronto fellowship-trained in neonatologyAssociate Professor of Pediatrics at a leading regional medical universityDeputy Chief Quality Officer at a leading tertiary referral centreMBA — healthcare management; published author on neonatal outcomesQualifications & Credentials
Medical Degrees
- MBBS / MD (Doctor of Medicine)
- Pediatrics Residency — Saudi Board / International Equivalent
- MBA — Alfaisal University, Riyadh
Fellowships & Special Training
- Fellowship in Neonatology — University of Toronto, Canada
- Advanced Training in Neonatal Quality Improvement
Certifications & Accreditations
- Saudi Commission for Health Specialties Registration
- Saudi Pediatric Association — Member
Areas of Expertise
Major Conditions Treated
- Prematurity & Low Birth Weight
- Neonatal Respiratory Distress Syndrome (RDS)
- Necrotizing Enterocolitis (NEC)
- Rh Alloimmunization & Hemolytic Disease of the Newborn
- Hypoxic-Ischemic Encephalopathy (HIE)
- Neonatal Sepsis
- Neonatal Hyperbilirubinemia
- Inborn Errors of Metabolism (Neonatal)
Sub-specialties
- Neonatal Critical Care: Comprehensive intensive care of premature and critically ill newborns — a leading neonatologist in Riyadh, Saudi Arabia.
- Neonatal Quality Improvement: Leadership in evidence-based neonatal quality improvement initiatives.
- Maternal-Foetal Medicine Collaboration: Multidisciplinary care of pregnancies complicated by Rh alloimmunization, IUGR, and prematurity.
Advanced Procedures & Treatments
- Neonatal Mechanical Ventilation (Conventional & HFOV)
- Surfactant Replacement Therapy
- Therapeutic Hypothermia
- Inhaled Nitric Oxide Therapy
- Exchange Transfusion
- Intravenous Immunoglobulin for HDN
Professional Experience
Current Affiliation
- Senior Consultant Neonatologist & Deputy Chief Quality Officer — King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia (Present)
Past Affiliations
- University of Toronto, Canada — Neonatology Fellowship Training
Academic & Research Roles
- Associate Professor of Pediatrics — Alfaisal University College of Medicine, Riyadh
- Deputy Chief Quality Officer — Quality & Patient Safety Programme
- Active researcher on neonatal Rh alloimmunization, NEC, and vitamin D outcomes
Key Achievements
- 20+ years of clinical experience in neonatology
- University of Toronto fellowship-trained in neonatal critical care
- Associate Professor with active academic and research leadership
- Deputy Chief Quality Officer with healthcare quality and MBA training
- Multiple peer-reviewed publications on neonatal outcomes
Awards & Recognitions
National & International Awards
- Information not publicly available for named awards; recognised as Associate Professor and Deputy Chief Quality Officer.
Professional Memberships
- Saudi Pediatric Association
- Saudi Neonatology Society
- American Academy of Pediatrics (Affiliation)
- Royal College of Physicians and Surgeons of Canada (Affiliation)
Research & Publications
Published Papers (Selected)
- Elsaidawi W, Hallak H, Alsadoun A, Almidani E, et al. Rhesus alloimmunization is correlated to necrotizing enterocolitis and respiratory distress: A tertiary center experience. 2024.
- Khan F, Syed F, AbdulMuthalib H, Almidani E, et al. Fetal malformations associated with exposure to mycophenolic acid during the first trimester. 2022.
- Almidani E et al. Maternal Vitamin D Levels and Its Correlation With Low Birth Weight in Neonates: A Tertiary Care Hospital Experience in Saudi Arabia. PMC8126481. 2021.
- Almidani E et al. Case Report of Transient Neonatal Hyperparathyroidism: Medically Free Mother. PMC7077087. 2020.
- Effects of intravenous human immunoglobulin on late hyporegenerative anemia secondary to rhesus hemolytic disease of the newborn. (Co-author)
Ongoing Research & Clinical Interests
- Rh alloimmunization and necrotizing enterocolitis
- Maternal vitamin D and neonatal outcomes
- Neonatal quality improvement
- Rare neonatal endocrine disorders
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Neonatology Consultation | ₹2,000 – ₹4,500 | $24 – $54 |
| NICU Admission (Daily, Non-Ventilated) | ₹15,000 – ₹40,000 | $180 – $480 |
| NICU Admission (Daily, Ventilated) | ₹35,000 – ₹85,000 | $420 – $1,020 |
| Surfactant Therapy for RDS | ₹25,000 – ₹75,000 | $300 – $900 |
| Therapeutic Hypothermia (Cooling) | ₹1,50,000 – ₹3,50,000 | $1,800 – $4,200 |
| Exchange Transfusion for Hyperbilirubinemia | ₹50,000 – ₹1,50,000 | $600 – $1,800 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Eyad Almidani, MD, MBA use in Neonatology treatment?
Dr. Eyad Almidani uses advanced neonatal critical care technologies including conventional and high-frequency mechanical ventilation, surfactant therapy, therapeutic hypothermia, inhaled nitric oxide, exchange transfusion, intravenous immunoglobulin for HDN, and evidence-based neonatal quality improvement protocols. Virtual consultations and remote second opinions are available to international families.
2. What conditions does Dr. Eyad Almidani, MD, MBA specialize in treating?
Dr. Eyad Almidani specialises in prematurity and low birth weight, neonatal RDS, necrotizing enterocolitis, Rh alloimmunization and HDN, hypoxic-ischemic encephalopathy, neonatal sepsis, hyperbilirubinemia, and neonatal inborn errors of metabolism in Riyadh, Saudi Arabia.
3. How do I book an appointment with Dr. Eyad Almidani, MD, MBA?
Appointments with Dr. Eyad Almidani, MD, MBA can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Eyad Almidani, MD, MBA?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Eyad Almidani, MD, MBA, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counseling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Eyad Almidani, MD, MBA offer second opinions for neonatology cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for paediatric families who wish to review their newborn's diagnosis or treatment plan with an expert neonatology specialist in Riyadh, Saudi Arabia.
